Top Markets
Coin of the day
Eli Lilly Eli Lilly

Eli Lilly

LLY
Hisse Senetlerindeki Sıralama #15
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Hisse Fiyatı
$910.55
Piyasa Değeri
$860.30B
Değişim (1 gün)
0.44%
Değişim (1 yıl)
5.28%
Ülke
US
Ticaret Eli Lilly (LLY)

Kategori

Eli Lilly (LLY) için temettü geçmişi
Eli Lilly (hisse sembolü: LLY) toplam 215 temettü ödemesi yaptı.
Tüm temettülerin toplamı (hisse bölünmeleriyle ayarlanmış): $72.49
Temettü verimi (TTM): 0.0063
Eli Lilly (LLY) için 1972 ile 2026 arasındaki temettü ödemeleri
Yıllık temettü ödemeleri
Yıl Temettü (hisse bölünmesiyle ayarlanmış) Değiştir
2026 (TTM) $1.73 -71.17%
2025 $6.00 15.38%
2024 $5.20 15.04%
2023 $4.52 15.31%
2022 $3.92 15.29%
2021 $3.40 14.86%
2020 $2.96 14.73%
2019 $2.58 14.67%
2018 $2.25 8.17%
2017 $2.08 1.96%
2016 $2.04 2.00%
2015 $2.00 2.04%
2014 $1.96 0.00%
2013 $1.96 0.00%
2012 $1.96 0.00%
2011 $1.96 0.00%
2010 $1.96 0.00%
2009 $1.96 4.26%
2008 $1.88 10.59%
2007 $1.70 6.25%
2006 $1.60 5.26%
2005 $1.52 7.04%
2004 $1.42 5.97%
2003 $1.34 8.06%
2002 $1.24 10.71%
2001 $1.12 7.69%
2000 $1.04 13.04%
1999 $0.92 15.00%
1998 $0.8 8.11%
1997 $0.74 8.00%
1996 $0.6852 4.58%
1995 $0.6552 4.80%
1994 $0.6252 3.30%
1993 $0.6052 10.04%
1992 $0.55 10.00%
1991 $0.5 21.95%
1990 $0.41 21.55%
1989 $0.3373 17.28%
1988 $0.2876 15.04%
1987 $0.25 11.01%
1986 $0.2252 12.60%
1985 $0.2 7.58%
1984 $0.1859 8.21%
1983 $0.1718 5.79%
1982 $0.1624 13.09%
1981 $0.1436 4.51%
1980 $0.1374 12.81%
1979 $0.1218 18.14%
1978 $0.1031 16.10%
1977 $0.0888 13.55%
1976 $0.0782 13.66%
1975 $0.0688 13.53%
1974 $0.0606 22.67%
1973 $0.0494 116.67%
1972 $0.0228 0.00%
Tüm temettü ödemelerinin listesi
Yıl Temettü Değiştir
2026 (TTM) $1.73 -71.17%
2025 $6.00 15.38%
2024 $5.20 15.04%
2023 $4.52 15.31%
2022 $3.92 15.29%
2021 $3.40 14.86%
2020 $2.96 14.73%
2019 $2.58 14.67%
2018 $2.25 8.17%
2017 $2.08 1.96%
2016 $2.04 2.00%
2015 $2.00 2.04%
2014 $1.96 0.00%
2013 $1.96 0.00%
2012 $1.96 0.00%
2011 $1.96 0.00%
2010 $1.96 0.00%
2009 $1.96 4.26%
2008 $1.88 10.59%
2007 $1.70 6.25%
2006 $1.60 5.26%
2005 $1.52 7.04%
2004 $1.42 5.97%
2003 $1.34 8.06%
2002 $1.24 10.71%
2001 $1.12 7.69%
2000 $1.04 13.04%
1999 $0.92 15.00%
1998 $0.8 -37.50%
1997 $1.28 -6.57%
1996 $1.37 -47.71%
1995 $2.62 4.80%
1994 $2.50 3.31%
1993 $2.42 10.00%
1992 $2.20 10.00%
1991 $2.00 21.95%
1990 $1.64 -2.73%
1989 $1.69 -26.70%
1988 $2.30 15.00%
1987 $2.00 11.11%
1986 $1.80 -43.75%
1985 $3.20 7.56%
1984 $2.98 8.18%
1983 $2.75 5.77%
1982 $2.60 13.04%
1981 $2.30 4.55%
1980 $2.20 12.82%
1979 $1.95 18.18%
1978 $1.65 16.20%
1977 $1.42 13.60%
1976 $1.25 13.64%
1975 $1.10 13.40%
1974 $0.97 22.47%
1973 $0.792 117.58%
1972 $0.364 0.00%
Benzer şirketler veya rakipler için temettü ödemeleri
Şirket Temettü ödemesi sayısı Ülke
67.00%
GB
225.00%
US
53.00%
US
32.00%
CH
223.00%
US